Key result
Selective ablation of RTN chemoreceptor neurons reduced the apnea-hypopnea index in heart failure rats compared to vehicle.
Why the study?
Enhanced central chemoreflex gain is observed in volume overload heart failure, but its role in developing respiratory and autonomic dysfunction remained to be determined.
In a rat model of volume overload heart failure, episodic hypercapnic stimulation triggers ventilatory plasticity and cardiorespiratory abnormalities that are largely dependent on RTN chemoreceptor neurons.
Answers are grounded in this paper and cite their sources.
May implicate RTN neurons in experimental HF apnea; leaves open translation to human central sleep apnea therapy.
Enhanced central chemoreflex (CC) gain is observed in volume overload heart failure (HF) and is correlated with autonomic dysfunction and breathing disorders. The aim of this study was to determine the role of the CC in the development of respiratory and autonomic dysfunction in HF. Volume overload was surgically created to induce HF in male Sprague-Dawley rats. Radiotelemetry transmitters were implanted for continuous monitoring of blood pressure and heart rate. After recovering from surgery, conscious unrestrained rats were exposed to episodic hypercapnic stimulation [EHS; 10 cycles/5 min, inspiratory fraction of carbon dioxide ([Formula: see text]) 7%] in a whole body plethysmograph for recording of cardiorespiratory function. To determine the contribution of CC to cardiorespiratory variables, selective ablation of chemoreceptor neurons within the retrotrapezoid nucleus (RTN) was performed via injection of saporin toxin conjugated to substance P (SSP-SAP). Vehicle-treated rats (HF+Veh and Sham+Veh) were used as controls for SSP-SAP experiments. Sixty minutes post-EHS, minute ventilation was depressed in sham animals relative to HF animals (ΔV̇e: −5.55 ± 2.10 vs. 1.24 ± 1.35 mL/min 100 g, P < 0.05; Sham+Veh vs. HF+Veh). Furthermore, EHS resulted in autonomic imbalance, cardiorespiratory entrainment, and ventilatory disturbances in HF+Veh but not Sham+Veh rats, and these effects were significantly attenuated by SSP-SAP treatment. Also, the apnea-hypopnea index (AHI) was significantly lower in HF+SSP-SAP rats compared with HF+Veh rats (AHI: 5.5 ± 0.8 vs. 14.4 ± 1.3 events/h, HF+SSP-SAP vs. HF+Veh, respectively, P < 0.05). Finally, EHS-induced respiratory-cardiovascular coupling in HF rats depends on RTN chemoreceptor neurons because it was reduced by SSP-SAP treatment. Overall, EHS triggers ventilatory plasticity and elicits cardiorespiratory abnormalities in HF that are largely dependent on RTN chemoreceptor neurons.
No takes yet. Share an insight, caveat, or question.
Díaz et al. (2019) studied Volume overload heart failure. Selective ablation of RTN chemoreceptor neurons via SSP-SAP vs. Vehicle was evaluated on Apnea-hypopnea index (AHI) (p=<0.05). Selective ablation of RTN chemoreceptor neurons reduced the apnea-hypopnea index in heart failure rats compared to vehicle.
Synapse has enriched 10 related papers. Consider them for comparative context: